Sigma Genetics is a biotechnology company that is building…
Existing methods for delivering genetic material into cells can be damaging, hard to scale, and unsuitable for non-invasive in vivo use.
Sigma Genetics develops magnetic-field devices that deliver DNA, RNA, and other charged molecules into cells as an alternative to electroporation.
Cell therapy developers, biopharma manufacturers, and researchers developing drug delivery, vaccines, and related biomedical applications.
Highly motivated to advance the healthcare field and I aspire to use both my business skills and scientific background to forward the medical industry. Interested in all things bio: cell/gene therapy, computational enzyme design, immunology, diagnostics, health devices, and so much more.
Matthew is a serial entrepreneur with a background in gene therapy and computer security. He has founded or co-founded five biotechnology companies and has played an integral role in the development of several advanced therapeutics, including three first-in-class treatment modalities. He is the author of dozens of patents covering innovations ranging from novel transfection technologies, immune cell programming, in vivo production of therapeutic proteins, senolytics, longevity, and oncology.




